Family Planning Services for Low-Income Women: The Role of Public Programs
This brief explains the major sources of public financing for family planning care, related policies, and their role financing services for low-income women.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief explains the major sources of public financing for family planning care, related policies, and their role financing services for low-income women.
This KFF analysis uses 2023 T-MSIS Research Identifiable Files to look at where reproductive-age female Medicaid enrollees received their last contraceptive visit by state. Overall, more than four in 10 (43%) female Medicaid enrollees received their last contraceptive visit of 2023 at a safety net provider, which includes Planned Parenthood clinics, community health centers, state and local health departments, and Indian health services, but there is wide variation by state.
This policy change will likely exacerbate fears among immigrant families about health officials and providers sharing patient information with ICE, increasing their reluctance to access health coverage or care.
This issue brief provides an overview of refugees and asylees in the U.S., trends in refugee and asylee admissions using data from the Department of Homeland Security (DHS), and recent changes in eligibility for assistance programs for refugees and asylees.
This State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.
This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the drug widely being considered a major advance, early evidence suggests that insurance coverage and benefit design decisions may create barriers to access.
Since President Trump took office in January 2025, four in ten immigrant adults say they have experienced negative health impacts due to immigration-related worries and about one in five say their child’s well-being has been impacted. Many also report skipping or delaying health care and avoiding applying for or stopping participation in government assistance programs, with some of the largest impacts among likely undocumented immigrants and immigrant parents.
This issue brief reviews the major sex education models and funding streams that are most commonly used, highlights state policies on sex education, and summarizes what is known about the impact of these programs and policies on teen sexual behavior and health outcomes.
The White House announcement focused on reducing the cost of some IVF drugs and clarifying options for employers to offer standalone fertility benefits for their employees and their dependents. This policy watch examines some key takeaways about the Trump IVF plan.
Medicare Advantage enrollees were in a plan that included just under half (48%) of all physicians available to traditional Medicare beneficiaries in their area in 2022, on average. The limitations of provider networks illustrate one of the key tradeoffs for beneficiaries in choosing Medicare Advantage for their coverage.
© 2025 KFF